Safety of bronchodilator reversibility test in elderly subjects: a prospective study

INTRODUCTION: The reversibility test measures an increase in ventilation parameters after the administration of 400 mg of a short-acting β-agonist (SABA). It is worth noting that a typical dosage, applied as a rescue medicine for bronchospastic dyspnoea, is significantly less, i.e., 100–200 mg. AIM:...

Descripción completa

Detalles Bibliográficos
Autores principales: Dor-Wojnarowska, Anna, Parużyńska, Anna, Kulczak, Aleksandra, Majewska-Pulsakowska, Marta, Szymala-Pędzik, Małgorzata, Machaj, Zbigniew, Sobieszczańska, Małgorzata, Poręba, Małgorzata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362750/
https://www.ncbi.nlm.nih.gov/pubmed/34408593
http://dx.doi.org/10.5114/ada.2020.92515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362750/
https://www.ncbi.nlm.nih.gov/pubmed/34408593
http://dx.doi.org/10.5114/ada.2020.92515

Ejemplares similares